Related Experiment Video
Updated: Sep 13, 2025
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
Human Amniotic Membrane Patch for Optic Disc Pit Maculopathy Remains Integrated at 2 Years.
Maram Alenazi1, Marco Mura1,2, Adel G Alakeely1,3
1King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
A human amniotic membrane patch effectively treated optic disc pit maculopathy in three patients, resolving fluid and improving vision. This innovative treatment offers a safe and promising option for this rare condition.
Area of Science:
- Ophthalmology
- Regenerative Medicine
Background:
- Optic disc pit maculopathy is a rare condition causing visual impairment.
- Current treatments have limited efficacy.
Observation:
- Three patients with optic disc pit maculopathy underwent pars plana vitrectomy and human amniotic membrane patch application.
- Outcomes included fluid resolution, visual acuity, and complications.
Findings:
- Complete resorption of subretinal fluid and reduced retinal thickness were observed.
- Significant improvements in visual acuity and microperimetry were noted.
- No complications or recurrences occurred; the patch remained visible for up to 26 months.
Implications:
- The human amniotic membrane patch demonstrates safety and efficacy in treating optic disc pit maculopathy.
- This approach offers a potential new therapeutic strategy for visual restoration.
- Further research may validate this regenerative treatment for similar ophthalmic conditions.
More Related Videos
07:48Engineering Transplantation-suitable Retinal Pigment Epithelium Tissue Derived from Human Embryonic Stem Cells
Published on: September 6, 2018
11:06Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care
Published on: November 11, 2022